October 16, 2015
MSD K.K. said on October 15 that it has filed a new drug application in Japan for its allergy treatment desloratadine, a second-generation histamine H 1 -receptor antagonist, which will be comarketed with Kyorin Pharmaceutical once approved. The expected indications...read more